Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

LL-37

Cathelicidin, hCAP-18, FALL-39, CAP-18

Quick Stats
Studies 2230
Trials 95
Score 2
2011 pubmed 46 citations

IL-4 and IL-13 exposure during mucociliary differentiation of bronchial epithelial cells increases antimicrobial activity and expression of antimicrobial peptides.

Zuyderduyn. Suzanne S; Ninaber. Dennis K DK; Schrumpf. Jasmijn A JA; van Sterkenburg. Marianne Aja MA; Verhoosel. Renate M RM; Prins. Frans A FA; van Wetering. Sandra S; Rabe. Klaus F KF; Hiemstra. Pieter S PS

Key Findings

  • IL‑4 and IL‑13 raise LL‑37 (hCAP18) mRNA and protein levels in bronchial epithelial cells
  • IL‑4 and IL‑13 also increase hBD‑2 production and overall antimicrobial activity against P. aeruginosa
  • No change was seen in other proteinase inhibitors (SLPI, elafin) and mucus production (MUC5AC) went up

Practical Outcomes

  • The results suggest that stimulating Th2 cytokine pathways could theoretically boost airway antimicrobial defenses, but there’s no proven, safe way for individuals to apply this. For now, the finding is mainly of scientific interest rather than a usable protocol for biohackers.

Summary

The study found that exposing airway cells to the immune signals IL‑4 or IL‑13 during their development makes them produce more of the antimicrobial peptide LL‑37 and another peptide called hBD‑2, which together boost the cells' ability to kill bacteria like Pseudomonas aeruginosa. However, this was done in lab-grown cells, not in people, so it doesn’t give a direct recipe for increasing LL‑37 in your own body.

Abstract

The airway epithelium forms a barrier against infection but also produces antimicrobial peptides (AMPs) and other inflammatory mediators to activate the immune system. It has been shown that in allergic disorders, Th2 cytokines may hamper the antimicrobial activity of the epithelium. However, the presence of Th2 cytokines also affects the composition of the epithelial layer which may alter its function. Therefore, we investigated whether exposure of human primary bronchial epithelial cells (PBEC) to Th2 cytokines during mucociliary differentiation affects expression of the human cathelicidin antimicrobial protein (hCAP18)/LL-37 and human beta defensins (hBD), and antimicrobial activity.PBEC were cultured at an air-liquid interface (ALI) for two weeks in the presence of various concentrations of IL-4 or IL-13. Changes in differentiation and in expression of various AMPs and the antimicrobial proteinase inhibitors secretory leukocyte protease inhibitor (SLPI) and elafin were investigated as well as antimicrobial activity.IL-4 and IL-13 increased mRNA expression of hCAP18/LL-37 and hBD-2. Dot blot analysis also showed an increase in hCAP18/LL-37 protein in apical washes of IL-4-treated ALI cultures, whereas Western Blot analysis showed expression of a protein of approximately 4.5 kDa in basal medium of IL-4-treated cultures. Using sandwich ELISA we found that also hBD-2 in apical washes was increased by both IL-4 and IL-13. SLPI and elafin levels were not affected by IL-4 or IL-13 at the mRNA or protein level. Apical wash obtained from IL-4- and IL-13-treated cultures displayed increased antimicrobial activity against Pseudomonas aeruginosa compared to medium-treated cultures. In addition, differentiation in the presence of Th2 cytokines resulted in increased MUC5AC production as has been shown previously.These data suggest that prolonged exposure to Th2 cytokines during mucociliary differentiation contributes to antimicrobial defence by increasing the expression and release of selected antimicrobial peptides and mucus.

Study Information

Provider

pubmed

Year

2011

Date

2011-05-02T00:00:00.000Z

DOI

10.1186/1465-9921-12-59

Citations

46

References

39